ALBO
Albireo Pharma Inc
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
96 hedge funds and large institutions have $362M invested in Albireo Pharma Inc in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% less capital invested
Capital invested by funds: $477M → $362M (-$115M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
96
Holding in Top 10
1
Calls
$1.99M
Puts
$886K
Top Buyers
| 1 | +$2.99M | |
| 2 | +$1.64M | |
| 3 | +$1.61M | |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$1.58M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.22M |
Top Sellers
| 1 | -$7.17M | |
| 2 | -$2.09M | |
| 3 | -$1.45M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.2M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$1.16M |